NanoCross™ Elite AB14W030100150 (UDI 00763000109820)Recalls & reported problems
Ev3, Inc · PTA AB14W030100150 NANOCROSS 014 V05 · Class 2
All models of NanoCross Elite (63)
Data updated Oct 18, 2026 from official FDA records · Editorial policy
- Adverse event reports
- 2
- Deaths reported
- 0
- Injuries reported
- 0
- Recalls naming it
- 0
Summary
The FDA's MAUDE database contains 2 adverse event reports that list this exact device (DI 00763000109820), received between Dec 7, 2021 and Mar 28, 2023 — classified as 2 malfunctions.
The most frequently reported specific device problem is “Burst Container or Vessel” (1 report).
1 other recall cover devices cleared under the same FDA submission (K141118); they may or may not involve this specific model.
Reports come from manufacturers, hospitals and patients and are not verified by the FDA. A report does not prove the device caused the event, and counts can't be used to compare devices or estimate failure rates. What reports can and can't tell you · How this data works · Data updated Oct 18, 2026.
Most reported problems
Device problems
- Burst Container or Vessel1
- Inflation Problem1
- Leak/Splash1
Patient problems
- No Clinical Signs, Symptoms or Conditions2
Recent adverse event reports
The 2 most recent of 2 reports, in the reporter's own words as published by the FDA.
MalfunctionMar 28, 2023Inflation Problem; Leak/Splash; Inflation Problem; Leak/Splash
A PHYSICIAN ATTEMPTED TO USE TWO NANOCROSS BALLOONS DURING TREATMENT OF CALCIFIED LESIONS WITH CHRONIC TOTAL OCCLUSION IN THE SUPERFICIAL FEMORAL ARTERY (SFA) AND THE TIBIAL/POPLITEAL TRUNK (TPT). THE DIAMETER OF THE SFA WAS 5MM AND THE TPT WAS 3MM. THE LENGTH OF THE LESION WAS 20-40MM. THE DEGREE OF TORTUOSITY AND CALCIFICATION WAS MODERATE. A 6FR NON MEDTRONIC SHEATH AND A NITRIX GUIDEWIRE WERE USED. THE DEVICES WERE PREPPED AS PER THE IFU WITH NO ISSUES IDENTIFIED. THE BALLOONS WERE INFLATED USING A NON MEDTRONIC DEVICE WITH HEP SALINE 60/CONTRAST 40. IT WAS REPORTED THE PHYSICIAN INITIALLY USED A 3MM BALLOON TO PRE DILATE THE CHRONIC TOTAL OCCLUSION IN THE SFA. HAWKPLUS M WAS USED SUCCESSFULLY. PHYSICIAN ATTEMPTED TO INFLATE A 5MM NANOCROSS BALLOON AND IT RUPTURED AT 8 ATM DURING THE INITIAL INFLATION AND WAS REMOVED INTACT WITH NO FRAGMENTS NOTED. THEN ATTEMPTED TO INFLATE A 3MM BALLOON IN THE TPT UNSUCCESSFULLY, IT DID NOT REGISTER PRESSURE AND HAD ONE INFLATION AT 8 ATM FOR TWO MINUTES, BURST AND WAS REMOVED INTACT WITH NO FRAGMENTS NOTED. THEY THEN USED 2.5-100 NANOCROSS SUCCESSFULLY IN TPT AND DEPLOYED AN ENTRUST STENT. THE SFA WAS POST DILATED WITH A NANOCROSS AT 8 ATM FO
Patient problems: No Clinical Signs, Symptoms or Conditions
MAUDE report 16626251 ↗MalfunctionDec 7, 2021Burst Container or Vessel; Burst Container or Vessel
PHYSICIAN ATTEMPTED TO USE A NANOCROSS PTA BALLOON WITH A 6FR, 45CM NON-MEDTRONIC SHEATH, 0.014, 300CM NON-MEDTRONIC GUIDEWIRE AND SPIDER FX EMBOLIC PROTECTION DEVICE DURING TREATMENT OF A CALCIFIED LESION IN THE PATIENT'S RIGHT MID AND DISTAL POPLITEAL ARTERY. SEVERE VESSEL CALCIFICATION AND SLIGHT TORTUOSITY ARE REPORTED. LESION EXHIBITED 80% STENOSIS. THERE WAS NO DAMAGE NOTED TO PACKAGING, I.E. SHELF CARTON, HOOP/TRAY. THERE WERE NO ISSUES NOTED WHEN REMOVING THE DEVICE FROM THE HOOP/TRAY. THE DEVICE WAS PREPPED AS PER IFU WITHOUT ISSUE. THE DEVICE WAS NOT PASSED THROUGH A PREVIOUSLY DEPLOYED STENT. RESISTANCE WAS NOTED DURING ADVANCEMENT BUT NO EXCESSIVE FORCE WAS USED. AN INFLATION DEVICE WAS USED FOR BALLOON INFLATION. A BALLOON BURST IS REPORTED DURING INFLATION TO 8ATM. NO BALLOON FRAGMENTS REMAIN IN THE PATIENT. ADDITIONAL PTA BALLOONS WERE USED TO COMPLETE THE PROCEDURE. NO PATIENT INJURY REPORTED.
Patient problems: No Clinical Signs, Symptoms or Conditions
MAUDE report 12949310 ↗
Recalls under the same FDA submission
These recalls involve devices cleared under K141118. One submission often covers many models, so check the product and lot details in each record.
- Z-0904-2025 · Dec 10, 2024 · Open, ClassifiedMedtronic NanoCross Elite PTA catheter, REF numbers amd sizes: 1) AB14W050020090, Size: 5MM X 20MM X 90CM; 2) AB14W050020150, Size: 5MM X 20MM X 150CM; 3) AB14W050040090,
Other Catheter, angioplasty, peripheral, transluminal devices
- Coyote™ ES H74939135152010Boston Scientific Corporation · Catheter, angioplasty, peripheral, transluminal879 reports
- Coyote™ ES H74939135204010Boston Scientific Corporation · Catheter, angioplasty, peripheral, transluminal585 reports
- Coyote™ ES H74939135202010Boston Scientific Corporation · Catheter, angioplasty, peripheral, transluminal437 reports
- Coyote™ ES H74939135304010Boston Scientific Corporation · Catheter, angioplasty, peripheral, transluminal384 reports
- Coyote™ ES H74939135404010Boston Scientific Corporation · Catheter, angioplasty, peripheral, transluminal293 reports
- Coyote™ ES H74939134152010Boston Scientific Corporation · Catheter, angioplasty, peripheral, transluminal279 reports
- Coyote™ H74939185202210Boston Scientific Corporation · Catheter, angioplasty, peripheral, transluminal200 reports
- Coyote™ ES H74939135254010Boston Scientific Corporation · Catheter, angioplasty, peripheral, transluminal127 reports
Sources and updates
- Device record: FDA GUDID, file dated Oct 13, 2026 · View this device in AccessGUDID ↗
- Adverse event reports: FDA MAUDE, file dated Oct 14, 2026 · each report above links to its original FDA record
- Recalls: FDA Medical Device Recalls, file dated Oct 16, 2026
- Page last rebuilt: Oct 18, 2026. Data downloaded through openFDA, which notes it is not validated for clinical or regulatory use.
How reports and recalls are matched · Editorial policy · Report an error on this page